Australia · Delayed Price · Currency is AUD HealthCo Healthcare and Wellness REIT Earnings Call Transcripts
Fiscal Year 2026
-
Portfolio value stands at AUD 1.4 billion with 99% occupancy and 4.2% NOI growth. Distributions remain paused due to Healthscope's receivership, but strong liquidity and prudent capital management support long-term stability.
Fiscal Year 2025
-
FY 2025 results were impacted by Healthscope's parent receivership, affecting 53% of earnings, but 98% rent collection and strong portfolio fundamentals were maintained. Distributions are paused and no FY 2026 guidance is provided until Healthscope is resolved.
-
Delivered 5% earnings growth and reaffirmed FY2025 guidance, with strong rent collection and stable asset values. Healthscope remains a key focus amid market speculation, with contingency plans and governance in place to protect unit holder value.
Fiscal Year 2024
-
FY 2024 saw 16% earnings growth, 100% rent collection, and strong balance sheet metrics, with a robust development pipeline and sustainability achievements. FY 2025 targets 5% earnings growth, continued asset recycling, and proactive capital management.